SNOA (STOCKS)
Sonoma Pharmaceuticals, Inc. Common Stock
$2.750000
-0.100000 (-3.51%)
Prev close: $2.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Amy M. Trombly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.76M
- Employees
- 168
- P/E (TTM)
- -1.30
- P/B (TTM)
- 1.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q2)
|
$-0.32 | $-0.32 | -0.0038 | -1.20% |
|
Jun 2025 (Q1)
|
$-0.76 | $-0.52 | -0.2367 | -45.23% |
|
Dec 2024 (Q3)
|
$-0.63 | $-0.70 | +0.0738 | +10.49% |
|
Sep 2024 (Q2)
|
$-0.59 | $-1.02 | +0.4300 | +42.16% |
Financial Statements
| Revenues | $17.72M |
| Benefits Costs and Expenses | $21.17M |
| Cost Of Revenue | $10.96M |
| Costs And Expenses | $21.17M |
| Gross Profit | $6.76M |
| Operating Expenses | $9.53M |
| Selling, General, and Administrative Expenses | $7.39M |
| Research and Development | $2.14M |
| Operating Income/Loss | -$2.77M |
| Income/Loss From Continuing Operations After Tax | -$3.37M |
| Income/Loss From Continuing Operations Before Tax | -$3.45M |
| Income Tax Expense/Benefit | -$80.00K |
| Net Income/Loss | -$2.82M |
| Net Income/Loss Attributable To Noncontrolling Interest | $547.00K |
| Net Income/Loss Attributable To Parent | -$3.37M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.37M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.95 |
| Diluted Earnings Per Share | -$1.95 |
| Basic Average Shares | 1,791,000 |
| Diluted Average Shares | 1,791,000 |
| Assets | $13.62M |
| Current Assets | $12.15M |
| Inventory | $3.70M |
| Other Current Assets | $8.44M |
| Noncurrent Assets | $1.48M |
| Fixed Assets | $314.00K |
| Other Non-current Assets | $1.16M |
| Liabilities | $10.19M |
| Current Liabilities | $4.22M |
| Accounts Payable | $1.65M |
| Other Current Liabilities | $2.57M |
| Noncurrent Liabilities | $5.97M |
| Equity | $3.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.43M |
| Liabilities And Equity | $13.62M |
| Net Cash Flow From Operating Activities | -$3.51M |
| Net Cash Flow From Operating Activities, Continuing | -$3.51M |
| Net Cash Flow From Investing Activities | -$210.00K |
| Net Cash Flow From Investing Activities, Continuing | -$210.00K |
| Net Cash Flow From Financing Activities | $332.00K |
| Net Cash Flow From Financing Activities, Continuing | $332.00K |
| Exchange Gains/Losses | $712.00K |
| Net Cash Flow | -$2.68M |
| Net Cash Flow, Continuing | -$3.39M |
| Comprehensive Income/Loss | -$2.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.01M |
| Other Comprehensive Income/Loss | $903.00K |